QuantumScape Corp【QS】

時価総額

$39.6億

PER

リチウム金属固体電池の新興企業。高エネルギー密度の固体電池技術と160超の米国特許を展開。フォルクスワーゲンとのライセンス移行、2023年8月の公募で3,750万株調達を実施。サンノゼ本社、従業員約800人（2024年12月31日時点）で米国中心に展開。

株価業績

サマリーテーブルに戻る

	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net loss	-1,100	-46	-412	-445	-478
Depreciation and amortization	8	11	28	42	58
Amortization of right-of-use assets and non-cash lease expense	-	-	8	8	8
Amortization of premiums and accretion of discounts on marketable securities	-1	-12	-4	19	29
Stock-based compensation expense	17	52	127	166	145
Fair Value Adjustment of Warrants	21	-	-	-	-
Change in fair value of convertible preferred stock tranche liabilities	-1,000	-	-	-	-
Change in fair value of assumed common stock warrant liabilities	-	-169	-	-	-
Write-off of property and equipment	-	-	14	22	13
Other	-	-1	-1	-0	-0
Prepaid expenses and other current assets and other assets	10	5	-5	8	1
Increase (Decrease) in Accounts Payable and Accrued Liabilities	2	6	6	-3	15
Operating lease liability	-1	-1	-1	-3	-5
Other liabilities	-	-	2	-0	-0
Net cash used in operating activities	-61	-128	-218	-240	-275
Purchases of property and equipment	24	127	159	85	62
Proceeds from maturities of marketable securities	113	894	837	1,042	1,485
Proceeds from sales of marketable securities	-	224	15	1	1
Purchases of marketable securities	892	1,377	570	1,111	1,295
Net cash provided by (used in) investing activities	-803	-386	124	-153	129
Proceeds from Stock Options Exercised	1	-	-	-	-
Proceeds from exercise of stock options and employee stock purchase plan	-	18	9	14	20
Proceeds from Warrant Exercises	-	151	-	-	-
Proceeds from Issuance of Common Stock	100	463	-	288	129
Proceeds from Issuance of Preferred Stock and Preference Stock	176	-	-	-	-
Proceeds from issuance of Class A Common Stock pursuant to Legacy QuantumScape Series F Preferred Stock Purchase Agreement, net of issuance costs	-	100	-	-	-
Business Combination, net of issuance costs paid	677	-1	-	-	-
Principal payment for finance lease	-	-	-	2	3
Dissolution of joint venture	-	-	-	-	2
Net cash provided by financing activities	954	737	9	300	144
Net increase (decrease) in cash, cash equivalents and restricted cash	90	223	-85	-92	-2
Cash paid for interest	-	0	2	2	2
Fair value of assumed common stock warrants exercised	-	521	-	-	-
Capital Expenditures Incurred but Not yet Paid	4	11	18	11	3
Business Combination transaction costs, accrued but not paid	1	-	-	-	-
Net assets assumed from Business Combination	1	-	-	-	-